U.S. federal trademark · Serial No. 79129012 · Reg. No. 4508626
Medicines and pharmaceutical preparations obtained by means of a purification process using aptamers for use in the treatment of hemophilia, immunology, infectious diseases, neuropathology, and oncology; medicines and pharmaceutical preparations containing a purified protein of interest obtained by separation of integral forms from truncated forms for use in the treatment of hemophilia, immunology, infectious diseases, neuropathology, and oncology; medicines and pharmaceutical preparations containing a purified protein of interest obtained by separation of forms modified by post-translational modification of unmodified or differently modified forms for use in the treatment of hemophilia, immunology, infectious diseases, neuropathology, and oncology; medicines and pharmaceutical preparations containing a purified protein of interest obtained by separation of active forms from inactive forms for use in the treatment of hemophilia, immunology, infectious diseases, neuropathology, and oncology
Contaminant removal services for the purpose of purification of chemical or biological compounds of interest; contaminant removal services for the purpose of purification of pharmaceutical compounds
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.